The Baker Brothers Return After Large Spike in Kodiak’s Stock Price – Insider Weekends

Kodiak Sciences Inc (KOD): $94.45

Market Cap: $5.92B

Enterprise Value: $5.85B

Introduction and Insider Purchase:

A little over a year ago, we wrote an Insider Weekends article about Madrigal Pharmaceuticals (MDGL), a biopharmaceutical company focused on treating metabolic dysfunction-associated steatohepatitis (MASH), a progressive liver disease that can lead to irreversible scarring of the liver (cirrhosis), liver failure, and death. That article was certainly one of my favorite Insider Weekends pieces from 2025, since the business had finally secured approval for its lead drug, Rezdiffra, and was at a financial inflection point as well.

Only plus or premium subscribers can access this post. Subscribe today.